ArticleFrontline gastroenterology2017

The impact of rifaximin-α on the hospital resource use associated with the management of patients with hepatic encephalopathy: a retrospective observational study (IMPRESS).

Mark Hudson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.